Beijing Tiantan Biological Products (SHSE:600161) Total Operating Expense: ¥805 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600161 Beijing Tiantan Biological Products Corp Ltd SHSE:600161
75 GF Score
Price ¥12.56
GF Value ¥23.94
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Beijing Tiantan Biological Products Total Operating Expense?

Beijing Tiantan Biological Products SHSE:600161 -3.01% 75 Total Operating Expense is ¥805 Mil as of Mar. 2026. GuruFocus rates SHSE:600161 with a GF Score™ of 75/100 and a GF Value™ of ¥23.94 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Beijing Tiantan Biological Products's Total Operating Expense for the three months ended in Mar. 2026 was ¥180 Mil. Beijing Tiantan Biological Products's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ¥805 Mil.

Beijing Tiantan Biological Products Total Operating Expense Related Terms

Beijing Tiantan Biological Products Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Beijing Tiantan Biological Products's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tiantan Biological Products Total Operating Expense Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 769.84 758.36 907.24 778.16 812.33

Beijing Tiantan Biological Products Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 187.40 168.97 212.84 243.13 180.09
SHSE:600161
75GF Score
Beijing Tiantan Biological Products Corp Ltd SHSE:600161
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tiantan Biological Products Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥805 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ¥805 Mil mean?
Beijing Tiantan Biological Products (SHSE:600161) has a Total Operating Expense of ¥805 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Beijing Tiantan Biological Products and its competitors.
Is Beijing Tiantan Biological Products' Total Operating Expense too high?
Beijing Tiantan Biological Products' current Total Operating Expense is ¥805 Mil. Overall, Beijing Tiantan Biological Products has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tiantan Biological Products' Total Operating Expense compare to VRTX and REGN?
Beijing Tiantan Biological Products' Total Operating Expense of ¥805 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Beijing Tiantan Biological Products and its competitors. Beijing Tiantan Biological Products's current Total Operating Expense is ¥805 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tiantan Biological Products stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products (SHSE:600161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥23.94, compared to a current price of ¥12.56 — trading 47.5% below its estimated fair value. The current Total Operating Expense is ¥805 Mil. Beijing Tiantan Biological Products' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Beijing Tiantan Biological Products (SHSE:600161), the current Total Operating Expense is ¥805 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tiantan Biological Products (SHSE:600161) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tiantan Biological Products stock appears to be undervalued. The current stock price of ¥12.56 is trading 47.5% below its estimated GF Value™ of ¥23.94. GuruFocus considers Beijing Tiantan Biological Products to be Significantly Undervalued.

Key valuation signals for SHSE:600161:

  • Total Operating Expense: ¥805 Mil
  • GF Value™: ¥23.94 vs. price of ¥12.56 (47.5% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tiantan Biological Products Business Description

Address No. 2, Shuangqiao Road, Chaoyang District, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.
75GF Score

Get the complete analysis for SHSE:600161

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.56
Price
¥23.94
GF Value